These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome. Tardy/Poncet B, Mahul P, Beraud AM, Favre JP, Tardy B, Guyotat D. Br J Haematol; 1995 Aug; 90(4):969-70. PubMed ID: 7669684 [No Abstract] [Full Text] [Related]
3. Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients. Burkhard-Meier U, Söhngen D, Schultheiss HP, Greinacher A, Schwartzkopff B, Vogt M, Heyll A, Schneider W. Intensive Care Med; 1995 Jun; 21(6):542-3. PubMed ID: 7560499 [No Abstract] [Full Text] [Related]
6. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia]. Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734 [No Abstract] [Full Text] [Related]
7. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia. Hale LP, Smith K, Braden GA, Owen J. Cathet Cardiovasc Diagn; 1998 Nov; 45(3):318-22. PubMed ID: 9829897 [Abstract] [Full Text] [Related]
8. [Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia]. Christin F, Theissen-Laval O, Loeb JP. Ann Fr Anesth Reanim; 1998 Nov; 17(1):82-3. PubMed ID: 9750692 [No Abstract] [Full Text] [Related]